tiprankstipranks
Trending News
More News >

BeOne Medicines Ltd. Strengthens Financial Oversight with Audit Committee Charter

Story Highlights
BeOne Medicines Ltd. Strengthens Financial Oversight with Audit Committee Charter

Confident Investing Starts Here:

The latest announcement is out from BeiGene Ltd ( (HK:6160) ).

BeOne Medicines Ltd. has outlined the purpose and structure of its Audit Committee, which is responsible for overseeing the integrity of the company’s financial reporting, the qualifications and performance of its independent auditors, and compliance with legal and regulatory requirements. The committee is composed of independent directors with financial expertise, meeting at least quarterly to ensure robust governance and accountability in financial matters, which is crucial for maintaining stakeholder trust and regulatory compliance.

The most recent analyst rating on (HK:6160) stock is a Buy with a HK$148.40 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.

More about BeiGene Ltd

Average Trading Volume: 6,619,453

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$235.8B

For a thorough assessment of 6160 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App